Cargando…
High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy
The primary central nervous system (CNS) presentation of lymphomatoid granulomatosis (LYG) is rare, and no standard therapy for LYG with primary CNS symptoms exists. CNS-LYG patients usually survive for only less than a year from diagnosis. This is the first report of high-grade primary CNS-LYG with...
Autores principales: | Harada, Sakiko, Ando, Jun, Ando, Miki, Nitta, Hideaki, Inano, Tadaaki, Hirasawa, Yusuke, Furukawa, Yoshiki, Kinoshita, Shintaro, Kondo, Akihide, Ohshima, Koichi, Komatsu, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710380/ https://www.ncbi.nlm.nih.gov/pubmed/34121006 http://dx.doi.org/10.2169/internalmedicine.7232-21 |
Ejemplares similares
-
Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid Arthritis
por: Hosoi, Hiroki, et al.
Publicado: (2022) -
Long-term spontaneous regression of Stage IV diffuse large B-cell lymphoma
por: Furukawa, Yoshiki, et al.
Publicado: (2021) -
Lymphomatoid Granulomatosis Treated Successfully with Rituximab in a Renal Transplant Patient
por: Castrale, Cindy, et al.
Publicado: (2011) -
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection
por: Furukawa, Yoshiki, et al.
Publicado: (2021) -
Intravascular large B-cell lymphoma as a recurrence of primary central nervous system lymphoma after chemotherapy: A case report
por: Edahiro, Yoko, et al.
Publicado: (2021)